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Edited by Robert BaroukiAbstract Intracellular protein degradation is a regulated pro-
cess with several proteolytic pathways. Although regulation of
macroautophagy has been investigated in some detail in hepato-
cytes and in few other cells, less is known on this regulation in
other cells and proteolytic pathways. We show that in human
ﬁbroblasts insulin and amino acids reduce protein degradation
by diﬀerent signalling pathways and that this inhibition proceeds
in part via the mammalian target of rapamycin, especially with
amino acids, which probably increase lysosomal pH. Moreover,
the regulatory amino acids (Phe, Arg, Met, Tyr, Trp and Cys)
are partially diﬀerent from other cells. Finally, and in addition
to macroautophagy, insulin and amino acids modify, to diﬀerent
extents and sometimes in opposite directions, the activities of
other proteolytic pathways.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Protein degradation and protein synthesis control in a coor-
dinate way the levels of intracellular proteins. The major reg-
ulators of protein metabolism are nutrients, such as amino
acids, and hormones, such as insulin. Thus, for example, it
has been clearly shown that nutrients promote protein synthe-
sis and inhibit protein degradation [1].
In mammalian cells there are about 500 diﬀerent proteases
[2], many of which are within the cells. However, most intracel-
lular proteases produce limited proteolysis and, therefore,
there are two main proteolytic pathways in the cells: lyso-
somes, which are cytoplasmic organelles, and proteasomes,
which are multicatalytic proteases localized in the cytosol
and in the nucleus. Both pathways are complex and degrade
intracellular proteins by diﬀerent mechanisms. Thus, within
lysosomal pathways, macroautophagy is an evolutionary con-
served process for bulk proteolysis under nutrient-poor condi-
tions [3]. However, there are also other lysosomal pathways of
protein degradation, including microautophagy and chaper-
one-mediated autophagy [4]. The main non-lysosomal proteo-
lytic pathways involve proteasomes, which degrade proteins by
ubiquitin-dependent and -independent mechanisms [5], but*Corresponding author. Fax: +34 96 3289701.
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doi:10.1016/j.febslet.2007.06.043other non-lysosomal proteases, including calpains and organ-
ellar proteases, can also degrade intracellular proteins to a,
comparatively, minor extent [6,7]. Although it is clear that pro-
tein degradation is carried out by these various pathways, reg-
ulation of macroautophagy by nutrients and hormones has
been mainly investigated [8] and it remains to be ﬁrmly estab-
lished if the activity of the other proteolytic pathways can be
also regulated.
In addition, most of these studies have been carried out in
liver or muscle [8], and it is unknown to what extent there
are cell variations in this regulation. Thus, for example,
although it has been proposed that the regulation of macro-
autophagy by amino acids in the liver involves the mammalian
target of rapamycin (mTOR) (see [8] and references cited
therein), this regulation occurs by a diﬀerent signalling route
in C2C12 myotubes [9].
In this report we have addressed three main questions on the
regulation of intracellular protein degradation. First, do the
inhibitions by insulin and amino acids overlap? Second, are
the regulatory amino acids in other cells the same than in liver
or muscle? Third, do insulin and amino acids regulate other
proteolytic pathways diﬀerent frommacroautophagy, in partic-
ular proteasomes? We have tried to answer these questions
using human skin ﬁbroblasts, because their similarity to their
in vivo counterparts and also because they can be relatively eas-
ily obtained from patients to investigate human pathologies.2. Materials and methods
2.1. Materials
Minimum essential medium (MEM), human insulin, 3-methylade-
nine, NH4Cl, E64d, pepstatin A, cycloheximide, monodansylcadaver-
ine (Fluka), o-phthaldialdehyde and the diﬀerent L-amino acids were
purchased from Sigma Chemical Co. MEM amino acids 50·, MEM
non-essential amino acids 100·, foetal calf serum, Lysotracker (Molec-
ular Probes) were supplied by Invitrogen Life Technologies. Lactacy-
stin was from Aﬃnity Research Products, leupeptin and N-Suc-
LLVY-MCA were from Peptide Institute, Inc. and rapamycin was
from Calbiochem. Most of the antibodies used have been described be-
fore [10,11]. In addition, phospho-speciﬁc antibodies which recognize
4E-BP1 (T37/T46) and p70S6K (T389), as well as their non-phos-
pho-speciﬁc antibodies, were from Cell Signalling and the mouse
monoclonal antibody to LC3 (clone 5F10) was from Nanotools.
Radioisotopes were obtained from Amersham Pharmacia Biotech.
Other reagents were of the best analytical quality available.
2.2. Cell culture
Normal human skin ﬁbroblasts were obtained from the Coriell Insti-
tute for Medical Research (Camden, NJ, USA). Cells were grown at
37 C in a humidiﬁed atmosphere of 5% (v/v) CO2/air in MEM withblished by Elsevier B.V. All rights reserved.
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essential amino acids, 1· MEM vitamins, 100 U/ml penicillin, 100 lg/
ml streptomycin (ﬁbroblasts’ growth medium) and containing or not
20% foetal calf serum. Cell viability and growth curves were deter-
mined in parallel for each culture. All experiments were performed
at 14–20 passage number to avoid culture aging eﬀects.2.3. Measurements of intracellular protein degradation
Fibroblasts were incubated for 48 h in fresh full medium with 5 lCi/
ml [3H]valine or, in some experiments (e.g. those to analyze the eﬀects
of valine), with 5 lCi/ml [3H]leucine, followed by a 24 h chase in fresh
full medium containing 10 mM L-valine (or 2 mM L-leucine) to de-
grade short-lived proteins [12]. Then, and to measure degradation of
long-lived proteins, all cultures were incubated for 4 h in Krebs–
Henseleit medium (118.4 mM NaCl, 4.75 mM KCl, 1.19 mM
KH2PO4, 2.54 mM MgSO4, 2.44 mM CaCl2 Æ 2H2O, 28.6 mM NaH-
CO3, 10 mM glucose) with 10 mM Hepes, pH 7.4, or in ﬁbroblasts’
growth medium, containing 10 mM L-valine (or 2 mM L-leucine) and
the indicated additions. Protein degradation was analyzed 1 h later
to ensure maximal eﬀects of the various additions and for only 3 h
to avoid possible secondary eﬀects, and was calculated at intervals of
1.5 h by measuring the net release of trichloroacetic acid-soluble radio-
activity from the labelled cells into the culture medium and expressed
as percentage protein degraded in 1.5 h. The contribution of the vari-
ous proteolytic pathways was calculated as previously described [13].Fig. 1. Eﬀects of insulin and/or amino acids on the degradation of
long-lived proteins in human ﬁbroblasts. Exponentially growing
human ﬁbroblasts were metabolically labelled with [3H]valine or
[3H]leucine for 48 h, chased for 24 h and then switched to ﬁbroblasts’
growth medium without (SW) or with (Med) 20% foetal calf serum or
to Krebs–Henseleit medium (KH) with the following additions (ﬁnal
concentrations): in A, 106 M insulin (In), and/or amino acids (Aa) at
two times the concentration present in the ﬁbroblasts’ growth medium;
in B, MEM amino acids (Es) and/or non-essential amino acids (Ne)
(see text) at two times the concentration present in the ﬁbroblasts’
growth medium, and/or 2 mM glutamine; and in C, each amino acid at
2 mM concentration. Protein degradation was measured, as described
in Section 2, after 1 h of the indicated additions and up to 4 h at 1.5 h
intervals (i.e. at 2.5 and 4 h chase). Results are the mean and S.D. from
eight to ﬁfteen separate experiments with duplicate samples. Stars
indicate statistically signiﬁcant diﬀerences from KH values at *P <
0.05, **P < 0.005, and ***P < 0.0005.2.4. General procedures
The immunoblotting procedure has been described [13]. With phos-
pho-speciﬁc antibodies, they were always used in the ﬁrst round of
immunoblotting. After treating the membrane with stripping buﬀer
(0.1 M glycine, pH 2.3), it was probed using the antibodies that recog-
nize the total amount of the speciﬁc protein of interest. Immunoﬂuo-
rescence microscopy and electron microscopic morphometry were
carried out as detailed in [14,15], respectively. Intracellular leucine
analysis was performed essentially as in [16], after derivatization of
amino acids with o-phthaldialdehyde, on a reversed-phase C18 column
(3.9 · 150 mm) and using a 717 (2 · 515) HPLC with a 2475 Multi k
Fluorescence Detector (Waters Corporation). Protein concentration
was measured with sodium deoxycholate, using bovine serum albumin
as the standard. The chymotrypsin-like activity of proteasomes in
crude cell extracts was determined, using N-Suc-LLVY-MCA, as the
diﬀerence between total activity and the remaining activity in the pres-
ence of 20 lM lactacystin [17]. Intracellular monodansylcadaverine
was measured (excitation wavelength 380 nm, emission wavelength
525 nm) in a Spectra Max M5 microplate reader (Molecular Devices)
and expressed as % speciﬁc activity (arbitrary units) as described
[18]. Comparisons between diﬀerent conditions were by Student’s t-
test. P < 0.05 was taken as signiﬁcant.3. Results
3.1. Insulin and amino acids inhibit the degradation of long-lived
proteins in human ﬁbroblasts in an additive way
In previous experiments, the eﬀects of various concentra-
tions of insulin and amino acids on protein degradation in hu-
man ﬁbroblasts incubated in Krebs–Henseleit medium for 4 h
or less were analyzed (data not shown). The highest inhibition
(Fig. 1A) was found at 106 M insulin and at an amino acid
concentration two times that present in the growth medium
(29% and 34% inhibitions, respectively). The inhibition pro-
duced when insulin and amino acids were added together
(63%) was clearly additive, indicating that they probably act
through diﬀerent signalling pathways. When the Krebs–Hense-
leit medium was replaced by ﬁbroblasts’ growth medium with-
out (SW) or with (Med) serum, the inhibitions (40% and 69%,
respectively) were only slightly below those obtained in Krebs–
Henseleit medium with amino acids alone or plus insulin,
respectively (see Fig. 1A), indicating that both are the maininhibitors of intracellular protein degradation in human ﬁbro-
blasts under these conditions.
We also investigated whether or not these inhibitions pro-
ceed via the mammalian target of rapamycin (mTOR) signal-
ling pathway (Fig. 2). Both insulin and amino acids
increased the phosphorylation of two substrates of mTOR,
4E-binding protein 1 (4E-BP1, Fig. 2A) and ribosomal S6 ki-
nase (p70S6K, Fig. 2B), in a rapamycin sensitive manner.
Also, the inhibition of protein degradation by insulin and espe-
cially by amino acids was, at least in part (20 ± 3% and
52 ± 4%, respectively), sensitive to this mTOR inhibitor and
these inhibitions were clearly additive (Fig. 2C).
3.2. The regulatory amino acids in human ﬁbroblasts are
partially diﬀerent from other cell types
To investigate which amino acids were regulatory, we ﬁrst
tested separately the three available commercial solutions
(see Section 2): a mixture of amino acids which are required
for growth (MEM amino acids: Arg, Cys, His, Ile, Leu, Lys,
Met, Phe, Thr, Trp, Tyr, Val), or of amino acids which can
be synthesized by the cells (Non-essential amino acids: Ala,
Asn, Asp, Glu, Gly, Pro, Ser) and Gln. As shown in Fig. 1B,
while non-essential amino acids (Ne) and Gln had no signiﬁ-
cant inhibitory eﬀect, MEM amino acids (Es) produced exactly
Fig. 2. Implication of mTOR in the inhibition of intracellular protein
degradation by insulin and/or amino acids. (A and B) Cells were
incubated for the indicated times in Krebs–Henseleit medium, in the
absence or in the presence of 200 nM rapamycin, and with insulin (In)
and/or amino acids (Aa) as shown. Cell lysates were analyzed by
Western blotting using phospho-speciﬁc antibodies for 4E-BP1 (P-4E-
BP1) (A) and p70S6K (P-p70S6K) (B) or antibodies that recognize the
total amount of the protein (4E-BP1 or p70S6K). (C) Human
ﬁbroblasts were radioactively labelled and protein degradation, with
or without insulin and/or amino acids and in the presence or not of
200 nM rapamycin as shown, was measured as described in the legend
to Fig. 1. Results are presented as the decrease in the percentage of the
labelled protein which is degraded in 1.5 h in Krebs–Henseleit medium
in the presence of insulin and/or amino acids as indicated and with
(gray bars) or without (black bars) rapamycin. Each value is the mean
and S.D. from at least six separate experiments with duplicate samples.
Diﬀerences from incubation values without rapamycin were found to
be statistically signiﬁcant at **P < 0.005 or ***P < 0.0005.
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we considered the possibility that protein synthesis was re-
quired for this inhibition. As shown in Fig. 3A and B, although
cycloheximide, which at the concentration here employed
inhibits protein synthesis by 97.1 ± 0.4%, reduced the cellular
fractional volume of autophagic vacuoles, amino acids further
decreased this parameter. Moreover, we found in pulse-chase
experiments that, while cycloheximide partially abolishes intra-
cellular protein degradation (36 ± 2%), the percentage of pro-
tein degraded which is inhibited by amino acids (or insulin)
was the same with or without protein synthesis (Fig. 3C). Also,
the protein degraded by macroautophagy in 1.5 h which is sen-
sitive to insulin or amino acids was not signiﬁcantly diﬀerent in
the absence (0.72 ± 0.10% or 0.82 ± 0.15%, respectively) or in
the presence (0.66 ± 0.05% or 0.79 ± 0.10%, respectively) of
cycloheximide. Finally, the ratios of the cytoplasmic (LC3-I)
to the membrane bound (LC3-II) forms of endogenous LC3,
after inhibition of lysosomal proteases [19], were essentially
comparable under the various conditions in control cells and
in cells treated with cycloheximide at two diﬀerent concentra-
tions (Fig. 3D). Thus, it appears that amino acids inhibit pro-tein degradation by a process which does not require protein
synthesis.
When the individual amino acids were tested separately
(Fig. 1C) at 2 mM concentration, it was found that only
Arg, Met, Phe, Trp, Tyr and, to a lesser extent, Cys signiﬁ-
cantly inhibited protein degradation. The inhibitory eﬀects of
the individual amino acids varied, being Phe the most eﬀective
inhibitor (20%), whereas Cys was the less eﬀective (6%). Sur-
prisingly, Leu and Gln, which are important regulators of pro-
tein degradation in other cell types, had no signiﬁcant eﬀects in
human ﬁbroblasts (Fig. 1C), even when added together (data
not shown). In the case of leucine, the possibility that its intra-
cellular concentration in human ﬁbroblasts may be very low
seems unlikely, since after addition of 1, 2 and 10 mM leucine
to the Krebs–Henseleit medium, the intracellular concentra-
tion of leucine in human ﬁbroblasts, measured by HPLC, rised
quickly from 6 ± 1 to 913 ± 100, 1385 ± 326 and 2567 ± 1273
nmols/g cell protein, respectively. Similar measurements car-
ried out in parallel in C2C12 myotubes (where leucine inhibits
protein degradation) indicated even lower intracellular leucine
concentrations: 6 ± 1 (without leucine), 95 ± 24 (1 mM leu-
cine), 242 ± 10 (2 mM leucine) and 981 ± 150 (10 mM leucine)
nmols/g cell protein. Therefore, it appears that the regulatory
amino acids vary in diﬀerent cell types.3.3. Insulin and amino acids regulate the activity of various
proteolytic pathways in human ﬁbroblasts
To investigate if only macroautophagy was aﬀected by ami-
no acids and insulin, we calculated ﬁrst, by previously de-
scribed procedures [13], the contribution of various pathways
to intracellular protein degradation in Krebs–Henseleit med-
ium and, then, we analyzed the variations produced when insu-
lin and/or amino acids were added. Fig. 4 shows that most
protein degradation in Krebs–Henseleit medium occurs by
macroautophagy and proteasomes (63% and 25%, respec-
tively). Insulin and amino acids, inhibited quite eﬀectively
(43% and 48%, respectively, and 92% both together) the degra-
dation of long-lived proteins by macroautophagy (Fig. 4A)
and also decreased (about 42% and 26%, respectively, and
66% when used together) the amount of proteins degraded
by proteasomes (Fig. 4B). In contrast, insulin and especially
amino acids apparently stimulated (about two and three times,
respectively) the degradation of proteins by lysosomal path-
ways diﬀerent from macroautophagy (other lysosomal,
Fig. 4C). Finally, insulin stimulated (1.6 times) the degradation
of non-lysosomal pathways which are diﬀerent from protea-
somes, while amino acids slightly inhibited (31%) this degrada-
tion (other non-lysosomal, Fig. 4D). Therefore, it appears that
the various proteolytic pathways are diﬀerently regulated.
Essentially the same eﬀects to those described for amino acids
alone or plus insulin, respectively, were found when using, as
controls, ﬁbroblasts’ growth medium without (SW) or with
(Med) serum (Fig. 4). In all these cases, the eﬀects of insulin
and amino acids were fully additive, in agreement with the re-
sults when analysing total protein degradation (see Fig. 1A).
We next investigated the eﬀects of insulin and of amino acids
on several lysosomal and proteasomal parameters. Under the
conditions of these experiments, neither insulin nor amino
acids produced variations in the levels of some lysosomal mar-
ker proteins, such as lamp-1, lamp-2 and cathepsin D (as stud-
ied by Western blot and immunoﬂuorescence) or in the
Fig. 3. Inhibition of protein synthesis does not aﬀect the regulation of protein degradation by amino acids in human ﬁbroblasts. (A) Representative
electron micrograph of the cells incubated in Krebs–Henseleit medium showing early (Avi) and late (Avd) autophagic vacuoles. Bar: 0.5 lm. (B) The
amounts of early (Avi) and late (Avd) autophagic vacuoles in cells incubated in Krebs–Henseleit medium in the presence (Aa) or not (KH) of amino
acids and treated or not with 100 lg/ml cycloheximide (CHX) were measured by electron microscopic morphometry. Each value is the mean and S.D.
from two separate experiments, with two diﬀerent blocks analyzed in each. Amino acids data, with or without cycloheximide, were compared with the
corresponding values without amino acids and diﬀerences were found to be statistically signiﬁcant at *P < 0.05 and **P < 0.005. (C) Human
ﬁbroblasts were radioactively labelled and incubated in Krebs–Henseleit medium with the indicated additions, in the presence (+CHX) or not (no
CHX) of 100 lg/ml cycloheximide and protein degradation was measured as described in the legend of Fig. 1. Each value is the mean and S.D. from
two separate experiments with duplicate samples. Diﬀerences from incubation values without cycloheximide were found to be statistically signiﬁcant
at ***P < 0.0005. (D) Western blotting of the autophagic marker protein LC3 in cells incubated in Krebs–Henseleit medium with the indicated
additions (KH, no additions; In, insulin; Aa, amino acids), in the presence of 10 lg/ml each of E64d and pepstatin A, and without (no CHX) or with
the indicated concentration of cycloheximide (CHX). The positions of LC3-I and LC3-II are indicated on the right and molecular-mass markers and
their size in kDa on the left.
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lin and amino acids reduced the lysosomal fractional volume
(by 55 ± 12% and 62 ± 9%, respectively), but, although when
insulin and amino acids were used together this decrease was
slightly higher (78 ± 6%) than when added separately, it was
not additive, in contrast with the inhibitions of intracellular
protein degradation. The main diﬀerences that we found in
the eﬀects of amino acids and insulin on lysosomes were
two: amino acids, but not insulin, produce a decrease in the
mean size of lysosomes (52 ± 27%, diﬀerences from controlor insulin values signiﬁcant at P < 0.0005) and in the ﬂuores-
cence intensity of Lysotracker (data not shown) and monodan-
sylcadaverine (Fig. 5). Since both stains accumulate in acidic
organelles, these diﬀerences may be related to an increase in
lysosomal pH produced by amino acids (compare Fig. 5B
and C and data in E).
Insulin and amino acids also aﬀect proteasomes, but, under
the conditions of the experiments (4 h incubations), they do
not modify in an ostensible way the levels of various subunits
of the 20S proteasomes and their regulatory complexes (C9, Z,
Fig. 4. Eﬀects of insulin and/or amino acids on the activities of the
various pathways of protein degradation. Human ﬁbroblasts were
radioactively labelled and incubated in Krebs–Henseleit medium with
the indicated additions as described in the legend of Fig. 1. The
contribution of macroautophagy (A), proteasomes (B), lysosomal
pathways diﬀerent from macroautophagy (C, other lysosomal) and
non-lysosomal pathways diﬀerent from proteasomes (D, other non-
lysosomal) to the degradation of proteins was calculated and results
are presented as percentage of the labelled protein which is degraded in
1.5 h by the various protein degradation pathways under the diﬀerent
conditions. Results are the mean and S.D. from eight to ﬁfteen
separate experiments with duplicate samples.
Fig. 5. Eﬀects of insulin and/or amino acids on monodansylcadaverine
staining of lysosomes. Cells were incubated in Krebs–Henseleit
medium (KH) for 90 min without (A) or with insulin (B), amino acids
(C) or insulin plus amino acids (D). Then, 50 lM monodansylcada-
verine was added for 10 min at 37 C and, after three washes with ice-
cold phosphate buﬀered saline, the cells were immediately observed by
ﬂuorescence microscopy using an inverted microscope. Bar: 10 lm. In
(E), intracellular monodansylcadaverine (MDC) was measured in KH
without or with insulin (In) and/or amino acids (Aa) as described in
Section 2. Data represent the mean and S.D. of four (In) or six (the
rest) diﬀerent experiments. Diﬀerences from KH values were found to
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tion of proteasomes (data not shown). However, they produce
a decrease in the chymotrypsin-like activity of proteasomes
(about 9 ± 6%, 13 ± 8% and 23 ± 6% in the presence of insulin,
amino acids, and both together, diﬀerences from control values
signiﬁcant at P < 0.05, P < 0.005 and P < 0.0005, respectively)
as well as a slight decrease in the amount of polyubiquitinated
proteins, which is more evident with insulin (Fig. 6).be statistically signiﬁcant at *P < 0.05 or ***P < 0.0005.4. Discussion
Variations in the concentrations of amino acids and insulin
regulate both protein synthesis and protein degradation in
some cell types (reviewed in [1]). In human ﬁbroblasts, insulin
and amino acids inhibit protein degradation independently of
each other, since, when added together, these eﬀects were addi-
tive. Therefore, apparently in these cells, the signalling path-
ways by which they control intracellular protein degradation
do not overlap, although it is usually believed, at least in cer-
tain cell types, that both converge at the level of mTOR [8].
Alternatively, it is possible that amino acids and/or insulin
modify the action of the other regulator, but since the additiv-
ity, even when analysing separately diﬀerent proteolytic path-
ways, is quite accurate, the ﬁrst possibility appears more
likely. In fact, it has been proposed, in isolated rat hepatocytes,
that insulin and amino acids control macroautophagy through
diﬀerent signalling pathways in relation to mTOR [20],
although this is not the prevalent point of view in those cells
(see e.g. [8]). In human ﬁbroblasts, and on the basis of theobserved eﬀects with rapamycin, mTOR appears to be clearly
implicated in the amino acid-dependent regulation of protein
breakdown. This is in agreement with initial observations in
hepatocytes of a correlation of the inhibition of protein degra-
dation by amino acids and phosphorylation of the small ribo-
somal subunit S6 [21] and with later results in other cells
(reviewed in [8,22]). Moreover, mTOR appears also to be
implicated, but to a lesser extent, in the insulin-dependent reg-
ulation. However, in both cases other signalling pathways dif-
ferent from mTOR should also contribute to this regulation,
because the inhibitions of protein degradation are only par-
tially sensitive to rapamycin, particularly in the case of insulin
(see Fig. 2C). In fact, additional mTOR-independent pathways
have been postulated for the regulation of macroautophagy
[23].
In human ﬁbroblasts there are diﬀerences with other cell
types in the nature of the regulatory amino acids of intracellu-
lar protein degradation. Thus, in rat liver, eight amino acids
(Leu, Gln, Tyr, Phe, Pro, Met, Trp and His) have a direct
Fig. 6. Insulin and, to a lesser extent, amino acids decrease the amount
of polyubiquitinated proteins. Extracts (75 lg protein) of cells incu-
bated for 30 min in Krebs–Henseleit medium (KH) without or with
insulin (In) and/or amino acids (Aa) were analyzed in a Western blot
using antibodies which recognize ubiquitinated proteins (A) or actin
(B) which served as a loading control. The positions of molecular-mass
markers and their size in kDa are indicated on the right.
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amino acids in human ﬁbroblasts are partially diﬀerent, since
Arg, and perhaps Cys, are also regulatory, while Leu, Gln,
Pro and His are not. This is particularly important with Leu,
since it has been found to inhibit protein degradation, not only
in liver but also in skeletal muscle and adipocytes (reviewed in
[8,22,25]), and it has been considered as the main signal for
amino acid availability [1,26]. In addition, it has been proposed
that Leu is recognized at the plasma membrane, indicating the
possible existence of an amino acid receptor/sensor for subse-
quent intracellular signalling (see e.g. [24]). Since Leu accumu-
lates within human ﬁbroblasts and has apparently no eﬀect on
intracellular protein degradation in these cells, the activity of
this hypothetical receptor may be cell-type dependent. Also,
it has been shown that the activities of the enzymes which
catabolyze leucine and the other branched chain amino acids
considerably diﬀer among various species and tissues [27,28].
Therefore, cell-dependent divergences in regulation may occur,
probably because protein degradation serves distinct physio-
logical roles in diﬀerent cell types, and the possibility that ami-
no acids regulate intracellular protein degradation by products
of their cell-speciﬁc metabolism can not be excluded. However,
this appears not to be the case for some of the observed Leu
eﬀects in other cells [29].
Among the various cellular proteolytic pathways, macro-
autophagy is considered a physiologically regulated mecha-
nism of bulk protein degradation, which modiﬁes its activity
in response to multiple signals [3,8]. In contrast, the ﬁne degra-
dation of speciﬁc proteins is mainly controlled by the ubiqui-
tin-proteasome pathway [30] and, therefore, it is usually
believed that regulation of this activity mainly occurs at the le-
vel of the substrate proteins. However, the enhanced proteoly-
sis produced in various pathological states in muscle cells has
been considered to be primarily due to activation of the ubiq-
uitin-proteasome system [31], and it has been also shown thatinsulin and amino acids can inhibit proteasomes [32,33]. Here
we show that insulin inhibits, to about the same extent, macro-
autophagy and proteasomes, whereas amino acids are more
eﬀective with macroautophagy. Therefore, it appears that pro-
teasomes and macroautophagy, the main proteolytic pathways
in mammalian cells, can be regulated by similar signals. In this
regard, it has been recently shown in C2C12 myotubes that
amino acids act additively with insulin to down regulate the
ubiquitin-proteasome pathway [34], in agreement with our
observations.
The inhibition of protein degradation produced by amino
acids, and also by insulin, does not require protein synthesis.
The most clear and common eﬀects on lysosomes of amino
acids and insulin are a decrease in their fractional volume in
a non-additive way, without modifying the levels or activities
of some major lysosomal components, and it appears also that,
as expected, there are some diﬀerences in their speciﬁc eﬀects
on lysosomes. In particular, the ﬂuorescence intensity of Lyso-
tracker (and also of monodansylcadaverine, because its stain-
ing derives from both interaction with autophagic membrane
lipids and accumulation in acidic compartments [35]), may ex-
plain, at least in part, the additive eﬀects of insulin and amino
acids on macroautophagic activity, with amino acids slightly
increasing lysosomal pH, while insulin inhibiting autophago-
some formation. However, additional work would be required
to test this possibility and to precisely work out the change in
lysosomal pH produced by amino acids. In this regard, we
have recently found, in a proteomics 2D-DIGE approach, that
the levels of various subunits (at least, subunits A, B, C and E)
of the vacuolar ATPase (which acidiﬁes lysosomes) decrease in
lysosomal membranes isolated from cells incubated in the pres-
ence of amino acids, when compared to cells incubated in their
absence (data not shown).
With proteasomes, the decreased activity of this pathway is
not associated with variations in localization or in the levels of
proteasomal subunits and only with a minor reduction in the
amount of polyubiquitinated proteins. Amino acids and insu-
lin also inhibit the chymotrypsin activity of proteasomes, but
only very slightly and, in contrast with the eﬀects in intact cells,
the former are more eﬀective than the latter. Therefore, some
additional mechanism, not yet identiﬁed, should contribute
to the inhibition of the activity of proteasomes in the cells,
especially in the case of insulin.
In addition to macroautophagy and proteasomes, there are
other minor proteolytic pathways operating in the cells
[4,6,7]. Here we show that insulin activates these pathways
whereas amino acids have a diﬀerential eﬀect, strongly activat-
ing lysosomal pathways diﬀerent from macroautophagy but
slightly inhibiting the non-lysosomal pathways diﬀerent from
proteasomes. The physiological meaning of the stimulation
of proteolysis in these systems, which is probably produced
by the diﬀerent regulation of at least some of them (e.g.
[36,37]), is unclear. There are several examples of collaboration
of proteolytic systems (proteasomes, macroautophagy, chaper-
one-mediated autophagy and calpains, shortly reviewed in
[38]) and a decreased activity of one of those can be compen-
sated by activation of other (see e.g. [39]). Here, probably be-
cause, compared to proteasomes and macroautophagy, the
activities of the lysosomal pathways diﬀerent from macroauto-
phagy and of the non-lysosomal pathways diﬀerent from pro-
teasomes are low (compare in Fig. 4 the absolute values of C
and D with those in A and B in Krebs–Henseleit medium),
I. Esteban et al. / FEBS Letters 581 (2007) 3415–3421 3421they could amend the decrease or even loss of some minor but
important function of proteasomes and/or macroautophagy,
when the general activities of these pathways are inhibited.
This remains to be investigated.
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